Life Science Market Research Reports

Global Malaria Ag Rapid Testing Market By Detection Type (Single Species and Multiple Species), By Target Antigen (HRP2, HRP3-based, pLDH and Others), By End User (Hospitals and Clinics, Diagnostic Centers, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Malaria Ag Rapid Testing Market size is expected to be worth around US$ 1,026.5 Million by 2034 from US$ 567.8 Million in 2024, growing at a CAGR of 6.1% d...
- ★★★★★
  
  ★★★★★
  
  (142)
- Nov 2025
- Pages: 357
- US $3,999 Onwards
- Formats:
Global Appetite Suppressants Market Analysis By Product Type (Prescription appetite suppressants (Liraglutide, Semaglutide, Tirzepatide, Naltrexone-bupropion, Phentermine-topiramate, Benzphetamine, Diethylpropion, Phendimetrazine, Phentermine), Non-prescription appetite suppressants (Caffeine-based supplements, Green tea extract, Glucomannan, Conjugated Linoleic Acid (CLA), Bitter Orange (Synephrine), Garcinia Cambogia, Others)), By Form (Tablets & capsules, Liquids, Powder, Others), By Route of Administration (Oral, Injectables, Transdermal patches), By Application (Obesity Management, Metabolic Health Support, Sports & Fitness Support, Bariatric Care Support), By Age Group (13-17 years, 18-30 years, 31-50 years, 50 years & above), By Gender (Female, Male), By Distribution Channel (Pharmacies & Drug Stores, Supermarkets & Hypermarkets, Specialty Nutrition & Wellness Stores, Online/e-commerce platforms, Others) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Appetite Suppressants Market size is expected to be worth around US$ 5.4 Billion by 2034, from US$ 2.7 Billion in 2024, growing at a CAGR of 7.1% during th...
- ★★★★★
  
  ★★★★★
  
  (142)
- Nov 2025
- Pages: 346
- US $3,999 Onwards
- Formats:
Global Rapid Hepatitis Testing Market By Test Type (Serologic Antibody Assays, Molecular HCV RNA Tests, Immunoassays for HCV Core Antigen), By Indication (Hepatitis A, Hepatitis B, Hepatitis C), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Companies – Industry Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025–2034

Report Overview Global Rapid Hepatitis Testing Market size is expected to be worth around US$ 6.23 Billion by 2034 from US$ 3.65 Billion in 2024, growing at a CAGR of 5.5% during the...
- ★★★★★
  
  ★★★★★
  
  (142)
- Nov 2025
- Pages: 237
- US $3,999 Onwards
- Formats:
Global Addison Disease Testing Market By Test Type (Laboratory testing, Imaging studies, Other specimen-based tests), By Technology (Immunoassays, Mass spectrometry, Point-of-care), By End-User (Hospitals, Diagnostic laboratories, and Clinics/ambulatory care settings), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Addison Disease Testing Market size is expected to be worth around US$ 376.6 Million by 2034 from US$ 249.6 Million in 2024, growing at a CAGR of 4.2% duri...
- ★★★★★
  
  ★★★★★
  
  (142)
- Nov 2025
- Pages: 346
- US $3,999 Onwards
- Formats:
Paediatric & Neonatal Testing Kits Market By Product Type (Assay Kits & Reagents, Instrument and, Consumables), By Test Type (Newborn Screening Panels, Genetic, Infectious Disease Testing, Hearing Screening, Critical Congenital Heart Defect (CCHD) Screening and Others), By End-User (Hospitals (NICUs / PICUs), Diagnostic Laboratories, Maternity & Specialty Clinics, and Point-of-Care Settings), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Paediatric & Neonatal Testing Kits Market Size is expected to be worth around US$ 4.17 billion by 2034 from US$ 2.24 billion in 2024, growing at a CAGR of 6.4...
- ★★★★★
  
  ★★★★★
  
  (142)
- Nov 2025
- Pages: 236
- US $3,999 Onwards
- Formats:
Global Small Molecule Inhibitors Market Analysis By Drug Class (Kinase Inhibitors (Tyrosine Kinase Inhibitors (TKIs) (EGFR inhibitors, ALK inhibitors, BTK inhibitors, VEGFR/FGFR inhibitors), Serine/Threonine Kinase Inhibitors (CDK inhibitors, mTOR/PI3K/AKT inhibitors, MEK/BRAF inhibitors)), Proteasome Inhibitors, MMPs and HSPs inhibitors, Small molecule inhibitors targeting the apoptosis, Immunomodulatory Small Molecule Inhibitors, Others), By Therapeutic Area (Oncology, Immunology & Autoimmune Disorders, Infectious Diseases, Neurology, Rare Diseases & Genetic Disorders, Others), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview The Global Small Molecule Inhibitors Market size is expected to be worth around US$ 622.6 Billion by 2034, from US$ 283.1 Billion in 2024, growing at a CAGR of 8.2% d...
- ★★★★★
  
  ★★★★★
  
  (142)
- Nov 2025
- Pages: 370
- US $3,999 Onwards
- Formats:

« Previous 1 … 53 54 55 56 57 … 360 Next »